Evaluating analytic models for individually randomized group treatment trials with complex clustering in nested and crossed designs
From MaRDI portal
(Redirected from Publication:6663830)
Cites work
- An improved approximation to the precision of fixed effects from restricted maximum likelihood
- Contamination: how much can an individually randomized trial tolerate?
- Designing individually randomized group treatment trials with repeated outcome measurements using generalized estimating equations
- Designing multicenter individually randomized group treatment trials
- How to design, analyse and report cluster randomised trials in medicine and health related research. Statistics in practice
- scientific article; zbMATH DE number 48701 (Why is no real title available?)
- Misspecified maximum likelihood estimates and generalized linear mixed models
- Optimal design of cluster randomized trials allowing unequal allocation of clusters and unequal cluster size between arms
- Sample size considerations for assessing treatment effect heterogeneity in randomized trials with heterogeneous intracluster correlations and variances
- Sample size for partially nested designs and other nested or crossed designs with a continuous outcome when adjusted for baseline
- Small Sample Inference for Fixed Effects from Restricted Maximum Likelihood
- The impact of ignoring multiple membership data structures in multilevel models
- Using simulation studies to evaluate statistical methods
This page was built for publication: Evaluating analytic models for individually randomized group treatment trials with complex clustering in nested and crossed designs
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q6663830)
